Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,925 | -32,147 | -33,316 | -11,378 | -2,928 |
| Depreciation Amortization | 1,114 | 1,854 | 842 | 716 | 420 |
| Accounts receivable | -555 | -44 | 1,111 | 937 | -4,115 |
| Accounts payable and accrued liabilities | -181 | 78 | 5,829 | -2,364 | -246 |
| Other Working Capital | 347 | -202 | 5,191 | 2,005 | -2,765 |
| Other Operating Activity | 8,600 | 10,022 | -565 | 280 | 6,698 |
| Operating Cash Flow | $-10,600 | $-20,439 | $-20,908 | $-9,804 | $-2,937 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124 | -190 | -1,321 | 4,786 | -1,505 |
| Purchase Sale Intangibles | -18 | -10 | -131 | -184 | -220 |
| Other Investing Activity | -41 | -59 | -454 | -184 | -220 |
| Investing Cash Flow | $-165 | $-249 | $-1,775 | $4,602 | $-1,725 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 10,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -5,000 |
| Common Stock Issued | 8,971 | 7,838 | 529 | 49,632 | 6,434 |
| Common Stock Repurchased | N/A | N/A | -404 | N/A | N/A |
| Other Financing Activity | -321 | -954 | -215 | -683 | -680 |
| Financing Cash Flow | $8,650 | $16,884 | $-90 | $48,949 | $754 |
| Beginning Cash Position | 18,812 | 22,616 | 45,389 | 1,642 | 5,550 |
| End Cash Position | 16,697 | 18,812 | 22,616 | 45,389 | 1,642 |
| Net Cash Flow | $-2,115 | $-3,804 | $-22,773 | $43,747 | $-3,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,600 | -20,439 | -20,908 | -9,804 | -2,937 |
| Capital Expenditure | -124 | -743 | -1,321 | -1,167 | -1,505 |
| Free Cash Flow | -10,724 | -21,182 | -22,229 | -10,971 | -4,442 |